Identifying combinations of long-term conditions associated with sarcopenia: a cross-sectional decision tree analysis in the UK Biobank study

BMJ Open. 2024 Sep 5;14(9):e085204. doi: 10.1136/bmjopen-2024-085204.

Abstract

Objectives: This study aims to determine whether machine learning can identify specific combinations of long-term conditions (LTC) associated with increased sarcopenia risk and hence address an important evidence gap-people with multiple LTC (MLTC) have increased risk of sarcopenia but it has not yet been established whether this is driven by specific combinations of LTC.

Design: Decision trees were used to identify combinations of LTC associated with increased sarcopenia risk. Participants were classified as being at risk of sarcopenia based on maximum grip strength of <32 kg for men and <19 kg for women. The combinations identified were triangulated with logistic regression.

Setting: UK Biobank.

Participants: UK Biobank participants with MLTC (two or more LTC) at baseline.

Results: Of 140 001 participants with MLTC (55.3% women, median age 61 years), 21.0% were at risk of sarcopenia. Decision trees identified several LTC combinations associated with an increased risk of sarcopenia. These included drug/alcohol misuse and osteoarthritis, and connective tissue disease and osteoporosis in men, which showed the relative excess risk of interaction of 3.91 (95% CI 1.71 to 7.51) and 2.27 (95% CI 0.02 to 5.91), respectively, in age-adjusted models.

Conclusion: Knowledge of LTC combinations associated with increased sarcopenia risk could aid the identification of individuals for targeted interventions, recruitment of participants to sarcopenia studies and contribute to the understanding of the aetiology of sarcopenia.

Keywords: aging; chronic disease; epidemiology; machine learning.

MeSH terms

  • Aged
  • Biological Specimen Banks
  • Cross-Sectional Studies
  • Decision Trees*
  • Female
  • Hand Strength
  • Humans
  • Logistic Models
  • Machine Learning
  • Male
  • Middle Aged
  • Risk Factors
  • Sarcopenia* / epidemiology
  • UK Biobank
  • United Kingdom / epidemiology